149 related articles for article (PubMed ID: 21933627)
21. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies.
Qian T; Zhang B; Qian C; He Y; Li Y
Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298
[TBL] [Abstract][Full Text] [Related]
22. Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype.
Tseden-Ish M; Choi YD; Cho HJ; Ban HJ; Oh IJ; Kim KS; Song SY; Na KJ; Ahn SJ; Choi S; Kim YC
Respirology; 2012 Jan; 17(1):127-33. PubMed ID: 21899657
[TBL] [Abstract][Full Text] [Related]
23. Distribution and susceptibility of ERCC1/XPF gene polymorphisms in Han and Uygur women with breast cancer in Xinjiang, China.
Li H; Zhou L; Ma J; Zhu Y; Fan J; Li N; Zheng Y; Sha T; Zhai Z; Ma B; Dai Z
Cancer Med; 2020 Dec; 9(24):9571-9580. PubMed ID: 33067872
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population.
Liu D; Liu X
Medicine (Baltimore); 2018 Dec; 97(49):e13358. PubMed ID: 30544402
[TBL] [Abstract][Full Text] [Related]
25. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
Zhou CX; Zhao JH
Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
[TBL] [Abstract][Full Text] [Related]
26. No association of the TGF-β1 29T/C polymorphism with breast cancer risk in Caucasian and Asian populations: evidence from a meta-analysis involving 55,841 subjects.
Alqumber MA; Dar SA; Haque S; Wahid M; Singh R; Akhter N
Asian Pac J Cancer Prev; 2014; 15(20):8725-34. PubMed ID: 25374198
[TBL] [Abstract][Full Text] [Related]
27. The association between XPG polymorphisms and cancer susceptibility: Evidence from observational studies.
Han C; Huang X; Hua R; Song S; Lyu L; Ta N; Zhu J; Zhang P
Medicine (Baltimore); 2017 Aug; 96(32):e7467. PubMed ID: 28796034
[TBL] [Abstract][Full Text] [Related]
28. Association of Rs11615 (C>T) in the excision repair cross-complementing group 1 gene with ovarian but not gynecological cancer susceptibility: a meta-analysis.
Ma YJ; Feng SC; Hu SL; Zhuang SH; Fu GH
Asian Pac J Cancer Prev; 2014; 15(15):6071-4. PubMed ID: 25124575
[TBL] [Abstract][Full Text] [Related]
29. Association between methylenetetrahydrofolate reductase (MTHFR) polymorphisms and lung cancer risk in Chinese people: An updated meta-analysis.
Zhong R; Chen Q; Zhang X; Li M; Zhang X; Lin W
Medicine (Baltimore); 2019 Jun; 98(24):e16037. PubMed ID: 31192962
[TBL] [Abstract][Full Text] [Related]
30. A Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-Analysis.
Han Y; Liu J; Sun M; Zhang Z; Liu C; Sun Y
Dis Markers; 2016; 2016():7643981. PubMed ID: 27057082
[TBL] [Abstract][Full Text] [Related]
31. Association between lncRNA H19 polymorphisms and cancer susceptibility based on a meta-analysis from 25 studies.
Liu C; Chen L; You Z; Wu Y; Wang C; Zhang G; Xu B; Chen M
Gene; 2020 Mar; 729():144317. PubMed ID: 31884107
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis identifies ERCC1 gene polymorphism as a predictor of better patient response to treatment with radiochemotherapy.
Li F; Xie X; Ren X; Zhang J
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1183-91. PubMed ID: 27100737
[TBL] [Abstract][Full Text] [Related]
33. The relevance of MTHFR C677T, A1298C, and MTRR A66G polymorphisms with response to male infertility in Asians: A meta-analysis.
Shi TL; Wu Y; Li Y; Chen ZF; Ma YN; Zhang ZT; Zhang YH; Zhang L
Medicine (Baltimore); 2019 Feb; 98(8):e14283. PubMed ID: 30813130
[TBL] [Abstract][Full Text] [Related]
34. Association of genetic polymorphisms in ERCC1 and ERCC2/XPD with risk of chronic benzene poisoning in a Chinese occupational population.
Xiao S; Gao L; Liu Y; Yu T; Jin C; Pan L; Zhu G; Lu X
Mutat Res; 2013 Feb; 751(1):52-8. PubMed ID: 23147699
[TBL] [Abstract][Full Text] [Related]
35. The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis.
Yang M; Zou Y; Bai Y; Li M
J Orthop Sci; 2015 Jan; 20(1):55-63. PubMed ID: 25270018
[TBL] [Abstract][Full Text] [Related]
36. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
Zhou W; Gurubhagavatula S; Liu G; Park S; Neuberg DS; Wain JC; Lynch TJ; Su L; Christiani DC
Clin Cancer Res; 2004 Aug; 10(15):4939-43. PubMed ID: 15297394
[TBL] [Abstract][Full Text] [Related]
37. Association of XPC polymorphisms and lung cancer risk: a meta-analysis.
Jin B; Dong Y; Zhang X; Wang H; Han B
PLoS One; 2014; 9(4):e93937. PubMed ID: 24736739
[TBL] [Abstract][Full Text] [Related]
38. Association of ERCC1 Polymorphisms with the Risk of Colorectal Cancer: A Meta-Analysis.
Chen J; Sun N; Hu G; Chen X; Jiang J; Wu H; Luo G
Crit Rev Eukaryot Gene Expr; 2017; 27(3):267-275. PubMed ID: 29199611
[TBL] [Abstract][Full Text] [Related]
39.
Li B; Shi X; Yuan Y; Peng M; Jin H; Qin D
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29752341
[TBL] [Abstract][Full Text] [Related]
40. ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females.
Yin Z; Su M; Li X; Li M; Ma R; He Q; Zhou B
J Exp Clin Cancer Res; 2009 Dec; 28(1):153. PubMed ID: 20003391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
